Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.
$4B
FY2025 · ▲ 11.1% vs FY2024
| Fiscal year | Year end | Deferred Tax Assets, Tax Credit Carryforwards, Research, by fiscal year |
|---|---|---|
| FY2025 | Sep 27, 2025 | $4,000,000,000 |
| FY2024 | Sep 28, 2024 | $3,600,000,000 |
| FY2023 | Sep 30, 2023 | $3,000,000,000 |
| FY2022 | Sep 24, 2022 | $2,500,000,000 |
| FY2021 | Sep 25, 2021 | $1,600,000,000 |
| Period | Length | Value | Last reported | Filings |
|---|---|---|---|---|
| Sep 27, 2025 | As of date | $4,000,000,000 | Oct 31, 2025 | 1 |
| Sep 28, 2024 | As of date | $3,600,000,000 | Nov 1, 2024 | 1 |
| Sep 30, 2023 | As of date | $3,000,000,000 | Nov 3, 2023 | 1 |
| Sep 24, 2022 | As of date | $2,500,000,000 | Oct 28, 2022 | 1 |
| Sep 25, 2021 | As of date | $1,600,000,000 | Oct 29, 2021 | 1 |